MétaCan
Menu
Back to cohort
Record W2773654851 · doi:10.1002/cncr.31164

Opioid use among cancer survivors: A call to action for oncology and primary care providers

2017· letter· en· W2773654851 on OpenAlexaboutno aff
Larissa Nekhlyudov, Olaf P. Geerse, Catherine M. Alfano

Bibliographic record

VenueCancer · 2017
Typeletter
Languageen
FieldMedicine
TopicCancer survivorship and care
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCancerMedical prescriptionRetrospective cohort studyPopulationLung cancerOpioidIntensive care medicineInternal medicine

Abstract

fetched live from OpenAlex

We thank Sutradhar et al for their valuable work on a critically important topic and herein provide several comments regarding their recent publication. 1 This retrospective study of a predominantly disadvantaged Canadian population of 17,202 individuals found a higher opioid prescribing rate among cancer survivors, defined as individuals who are at least 5 years after diagnosis, compared with 8601 matched controls without a prior cancer diagnosis.After multivariable adjustment, the opioid prescribing rate was 1.22 times higher among survivors compared with controls.The difference in opioid prescribing rates was especially pronounced among survivors of noncolorectal gastrointestinal, gynecologic, and lung cancers.Surprisingly, a higher prescribing rate persisted even among survivors >10 years beyond diagnosis.Cancer survivors face a wide variety of physical and psychological challenges that may prevail for years, even decades, after treatment.[2][3][4][5][6] When examining the prevalence of health conditions among survivors using retrospective data, it often is unclear whether these conditions existed before the diagnosis of cancer, emerged during treatment, or are due to the late effects of cancer treatment.Unfortunately, the study by Sutradhar et al does not provide insights into the initiation of the opioids (including which provider prescribed the drugs and for what indication [ie, cancer or otherwise]) or assess differences in opioid prescriptions by cancer stage or treatment type.Furthermore, it is not clear from the published study why survivors continued to receive opioid medications (ie, whether they were receiving the drugs as part of a thoughtful, ongoing pain management plan or whether these prescriptions were inadvertently continued as "remnants" from cancer treatment).Addressing these questions is of vital importance when trying to understand how targeted interventions to potentially reduce opioid prescriptions for cancer survivors may be developed.Cancer survivors are at risk of persistent pain, which may be due to a variety of treatment exposures, including chemotherapy-related neuropathy, radiation-related fibrosis, and surgery (ie, amputation or adhesions).7,8 In addition to Cancer

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.037
metaresearch head score (Gemma)0.126
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.046
Threshold uncertainty score0.197

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0370.126
Meta-epidemiology (narrow)0.0010.002
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0030.003
Science and technology studies0.0070.007
Scholarly communication0.0100.025
Open science0.0080.009
Research integrity0.0460.038
Insufficient payload (model declined to judge)0.0170.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.346
Teacher spread0.294 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueCancerSame topicCancer survivorship and careFrench-language works237,207